Reducing Hemarthrosis in ACL Reconstruction With BTB Autograft by the Administration of Intravenous TXA
Status:
Completed
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the proposed study is to evaluate the effects of administering intravenous
tranexamic acid (TXA) to patients undergoing anterior cruciate ligament (ACL) reconstruction
with bone-patellar tendon-bone autograft to minimize hemarthrosis within the knee joint and
post operative pain.
Phase:
Phase 4
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health